While the PwC tracking survey of VC investment in life sciences (including medical devices) shows definite global cooling [TTA 26 April], a $130 million venture funder is just warming up. Aberdare Ventures is one of the top three, after Qualcomm and Merck, making investments in four or more digital health companies, according to RockHealth, and moving away from other parts of life science. Funding for their present suite of seven firms is between $3 and $5 million each. The firm’s latest acquisition is partner Mohit “Mo” Kaushal from West Health. Forbes
[Unrelated editorial note: This is the 5,000th news item on this site.]
Most Recent Comments